{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:31:47Z","timestamp":1779237107819,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bmcl.2017.02.070","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T02:45:12Z","timestamp":1489113912000},"page":"1744-1749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho\/MRTF\/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma"],"prefix":"10.1016","volume":"27","author":[{"given":"Kim M.","family":"Hutchings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika M.","family":"Lisabeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walajapet","family":"Rajeswaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roderick J.","family":"Sorenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Ruth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Suen","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Leipprandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel R.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Neubig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bmcl.2017.02.070_b0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nm0510-523","article-title":"Fibrosis under arrest","volume":"16","author":"Wynn","year":"2010","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.bmcl.2017.02.070_b0010","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.bmcl.2017.02.070_b0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/14728214.2012.678833","article-title":"Emerging targets for the treatment of scleroderma","volume":"17","author":"Leask","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"issue":"5","key":"10.1016\/j.bmcl.2017.02.070_b0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MCP.0b013e328356800f","article-title":"Into the matrix: targeting fibroblasts in pulmonary fibrosis","volume":"18","author":"Sivakumar","year":"2012","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"10.1016\/j.bmcl.2017.02.070_b0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrm2890","article-title":"Linking actin dynamics and gene transcription to drive cellular motile functions","volume":"11","author":"Olson","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.bmcl.2017.02.070_b0030","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1152\/ajpcell.00060.2014","article-title":"Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription","volume":"307","author":"Tsou","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.bmcl.2017.02.070_b0035","doi-asserted-by":"crossref","first-page":"L656","DOI":"10.1152\/ajplung.00166.2011","article-title":"Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-beta","volume":"301","author":"Sandbo","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.bmcl.2017.02.070_b0040","doi-asserted-by":"crossref","first-page":"e0126015","DOI":"10.1371\/journal.pone.0126015","article-title":"A role of myocardin related transcription factor-A (MRTF-A) in scleroderma related fibrosis","volume":"10","author":"Shiwen","year":"2015","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.bmcl.2017.02.070_b0045","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1535-7163.MCT-06-0782","article-title":"CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling","volume":"6","author":"Evelyn","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2017.02.070_b0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bmcl.2009.11.056","article-title":"Design, synthesis and prostate cancer cell-based studies of analogs of the Rho\/MKL1 transcriptional pathway inhibitor, CCG-1423","volume":"20","author":"Evelyn","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"10.1016\/j.bmcl.2017.02.070_b0055","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1016\/j.bmcl.2013.04.080","article-title":"Optimization of novel nipecotic bis(amide) inhibitors of the Rho\/MKL1\/SRF transcriptional pathway as potential anti-metastasis agents","volume":"23","author":"Bell","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmcl.2017.02.070_b0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.MIB.0000437615.98881.31","article-title":"Novel Rho\/MRTF\/SRF inhibitors block matrix-stiffness and TGF-beta-induced fibrogenesis in human colonic myofibroblasts","volume":"20","author":"Johnson","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.bmcl.2017.02.070_b0065","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ajpath.2014.12.005","article-title":"Inhibition of myocardin-related transcription factor\/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis","volume":"185","author":"Sisson","year":"2015","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.bmcl.2017.02.070_b0070","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1124\/jpet.114.213520","article-title":"Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor\/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury","volume":"349","author":"Haak","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.bmcl.2017.02.070_b0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/ml100016x","article-title":"SMARTCyp: A 2D method for prediction of cytochrome P450-mediated drug metabolism","volume":"1","author":"Rydberg","year":"2010","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmcl.2017.02.070_b0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ml200246f","article-title":"Ligand-based site of metabolism prediction for cytochrome P450 2D6","volume":"3","author":"Rydberg","year":"2012","journal-title":"ACS Med Chem Lett"},{"issue":"9","key":"10.1016\/j.bmcl.2017.02.070_b0085","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/tx200168d","article-title":"Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States","volume":"24","author":"Stepan","year":"2011","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bmcl.2017.02.070_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-00212-w","article-title":"Local delivery of novel MRTF\/SRF inhibitor prevents scar tissue formation in a preclinical model of fibrosis","author":"Yu-Wai-Man","year":"2017","journal-title":"Sci Rep"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17302093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17302093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:14:52Z","timestamp":1760771692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17302093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0960894X17302093"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.02.070","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho\/MRTF\/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.02.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}